hotspot -WSS

hotspot

author：entertainment 2025-09-30 08:27:05 - browse：13497

Balance innovation — A federal judge made a key ruling in a lawsuit challenging a new drug pricing program Adobe

WASHINGTON — A federal court judge allowed a new Medicare drug price negotiation program to proceed while the court deliberates whether it is constitutional.

The case centers on Democrats’ new law, which empowered the Medicare program to start negotiating lower prices for certain medicines that are especially expensive for the government. Judge Michael Newman, a Trump appointee to the U.S. District Court for the Southern District of Ohio, ruled against the U.S. Chamber of Commerce, which had sued the federal government and asked for the program to be stopped while litigation continues.

Medicare officials announced the first 10 drugs they would negotiate over last month, and the deadline for the pharmaceutical companies to sign agreements to start bargaining is Oct. 1. The Chamber of Commerce had requested a decision on the preliminary injunction by that date.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Ventyx halts psoriasis drug development after lackluster trial results

explore

WSS

Hospitals use virtual reality to design more inclusive rooms for kids

Choosing scientific sides in the fight against Alzheimer's

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Astronauts get first look at the spacecraft that will fly them around the moon

CDC launches VaccineFinder tool to locate Covid

Experimental asthma app from Apple and Anthem shows promise

leisure time

hotspot

focus

Medicare details structure of new drug price negotiation program

Former Georgia lieutenant governor says he received grand jury subpoena

Continuity nursing helped my family in our darkest PICU moments

White House drug czar issues call for 'recovery

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Choosing scientific sides in the fight against Alzheimer's

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

After affirmative action ruling, medical educators look to 'holistic review'

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

focus

Travel bans should be based on evidence, not politics or fear

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Ventyx halts psoriasis drug development after lackluster trial results

What health policies could hitch a ride on a spending bill?

Study suggests Covid rebound is far more common with Paxlovid than without

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

hotspot

leisure time

explore

focus